Heart failure due to severe hypertrophic cardiomyopathy reversed by low calorie, high protein dietary adjustments in a glycogen storage disease type IIIa patient

JIMD Reports

Volumn 5, Issue , 2012, Pages 13-16

  Sentner, Christiaan P ^a   Caliskan, Kadir ^b   Vletter, Wim B ^b   Smit, G Peter A ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Concentric left ventricular hypertrophy; Debranching enzyme; Glycogen storage disease type; High protein diet; Left ventricular hypertrophy

Indexed keywords

EID: 84904312832     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2011_111     Document Type: Chapter

References (22)

1. Akazawa H, Kuroda T, Kim S, Mito H, Kojo T, Shimada K (1997) Specific heart muscle disease associated with glycogen storage disease type III: clinical similarity to the dilated phase of hypertrophic cardiomyopathy. Eur Heart J 18:532–533
2. Carvalho JS, Matthews EE, Leonard JV, Deanfield J (1993) Cardiomyopathy of glycogen storage disease type III. Heart Vessels 8:155–159
3. Chen YT (2001) Glycogen storage diseases. In: Scriver CR et al (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill Professional, New York, pp 1521–1551
4. Coleman RA, Winter HS, Wolf B, Gilchrist JM, Chen YT (1992) Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med 116:896–900
5. Dagli AI, Zori RT, McCune H, Ivsic T, Maisenbacher MK, Weinstein DA (2009) Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet. J Inherit Metab Dis Epub Mar 30
6. Goodpaster BH, Kelley DE, Wing RR, Meier A, Theate FL (1999) Effects of weight loss on insulin sensitivity in obesity – influence of regional adiposity. Diabetes 48:839–847
7. Gremse DA, Bucuvalas JC, Balisteri WF (1990) Efficacy of cornstarch therapy in type III glycogen-storage disease. Am J Clin Nutr 52:671–674
8. Kelley DE, Slasky S, Janosky J (1991) Effects of obesity and non-insulin dependent diabetes mellitus. Am J Clin Nutr 54:509–515
9. Kiechl S, Willeit J, Vogel W, Kohlendorfer U, Poewe W (1999) Reversible severe myopathy of respiratory muscles due to adult-onset type III glycogenosis. Neuromuscul Disord 9:408–410
10. Labrune P, Huguet P, Odievre M (1991) Cardiomyopathy in glycogen-storage disease type III: clinical and echographic study of 18 patients. Pediatr Cardiol 12:161–163
11. Lee PJ, Deanfield JE, Burch M, Baig K, McKenna WJ, Leonard JV (1997) Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III. Am J Cardiol 79:834–838
12. Lucchiari S, Pagliarani S, Salani S et al (2006) Hepatic and neuromuscular forms of glycogenosis type III: nine mutations in AGL. Hum Mutat 27:600–601
13. Moses SW, Wanderman KL, Myroz A, Frydman M (1989) Cardiac involvement in glycogen storage disease type III. Eur J Pediatr 148:764–766
14. Olson LJ, Reeder GS, Noller KL, Edwards WD, Howell RR, Michels VV (1984) Cardiac involvement in glycogen storage disease III: morphologic and biochemical characterization with endomyocardial biopsy. Am J Cardiol 53:980–981
15. Shen J, Bao Y, Liu HM, Lee PJ, Leonard JV, Chen YT (1996) Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest 98:352–357
16. Slonim AE, Weisberg C, Benke P, Evans OB, Burr IM (1982) Reversal of debrancher deficiency myopathy by the use of high-protein nutrition. Ann Neurol 11:420–422
17. Slonim AE, Coleman RA, Moses SW (1984) Myopathy and growth failure in debrancher enzyme deficiency: improvement with high protein noctural enteral therapy. J Pediatr 105:906–911
18. Smit GP, Fernandes J, Leonard JV et al (1990) The long-term outcome of patients with glycogen storage diseases. J Inherit Metab Dis 13:411–418
19. Smit GPA, Rake JP, Akman HO, DiMauro S (2006) The glycogen storage diseases and related disorders. In: Fernandes J, Saudubray J-M, van den Berghe G, Walter JH (eds) Inborn metabolic diseases: diagnosis and treatment. Springer Medizin, Heidelberg, pp 103–116
20. Talente GM, Coleman RA, Alter C et al (1994) Glycogen storage disease in adults. Ann Intern Med 120:218–226
21. Valayannopoulos V, Bajolle F, Arnoux JB et al (2011) Successful treatment of severe cardiomyopathy in glycogen storage disease type III with D,L-3-hydroxybutyrate, ketogenic and high protein diet. Pediatr Res 70(6):638–641
22. Wolfsdorf JI, Weinstein DA (2003) Glycogen storage diseases. Rev Endocr Metab Disord 4:95–102